Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round:

Union Pacific (UNP) - Get Report : "That's a great long-term situation."

Pfizer (PFE) - Get Report : "Pfizer is disappointing, which is why I like Merck (MRK) - Get Report and AbbVie (ABBV) - Get Report ."

Teva Pharmaceuticals (TEVA) - Get Report : "I don't like Teva. I'd let this one go."

ABM Industries (ABM) - Get Report : "I've liked this one for a long time."

Schlumberger (SLB) - Get Report : "I don't want you anywhere near this house of pain."

PagSeguro Digital (PAGS) - Get Report : "I can't bless this one. Brazil is too hard."

Save 57% With Our Labor Day Sale. Join Jim Cramer's Action Alerts PLUS investment club to become a smarter investor. Click here to sign up.

On Real Money, Cramer keys in on the companies and CEOs he knows best. Get more of his insights with a free trial subscription to Real Money.

Introducing TheStreet Courses: Financial titans Jim Cramer and Robert Powell are bringing their market savvy and investing strategies to you. Learn how to create tax-efficient income, avoid top mistakes, reduce risk and more. With our courses, you will have the tools and knowledge needed to achieve your financial goals. Learn more about TheStreet Courses on investing and personal finance here.

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

To read a full recap of this episode of "Mad Money," click here.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

At the time of publication, Cramer's Action Alerts PLUS had a position in SLB.